Loading...
Shanghai Pharmaceuticals Holding Co., Ltd
SHPMF•PNK
Healthcare
Medical - Distribution
$1.46
$0.00(0.00%)
U.S. Market opens in 13h 42mShanghai Pharmaceuticals Holding Co., Ltd (SHPMF) AI-Powered Stock Analysis
See how Shanghai Pharmaceuticals Holding Co., Ltd scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerShanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Stock Overall Grade
Shanghai Pharmaceuticals Holding Co., Ltd’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Shanghai Pharmaceuticals Holding Co., Ltd's overall stock rating.
Forecast
C+Score
55/100Financial Growth
C+Score
50/100Fundamental Growth
B+Score
71/100Key Ratios
AScore
80/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (50/100, C+) and Fundamental Growth (71/100, B+) highlight its stability, while Key Ratios (80/100, A) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Shanghai Pharmaceuticals Holding Co., Ltd stock grade, including financials, comparisons, and forecasts.